Diabetes Drug Developments At Sanofi-Aventis, Merck
Diabetes Drug Developments At Sanofi-Aventis, Merck
Sanofi’s study of diabetes patients using Lantus in combination with Apidra showed improved patient outcomes.
Read more on Forbes
Health Blog with videos and articles
Diabetes Drug Developments At Sanofi-Aventis, Merck
Sanofi’s study of diabetes patients using Lantus in combination with Apidra showed improved patient outcomes.
Read more on Forbes